Both for serum and plasma, levels for four proteins, CA3, ETFA, MYL3, and MDH2, were significantly different between DMD patients compared to controls, as shown in Fig 3A. These proteins allowed separation of DMD patients from both healthy controls and female carriers. This evidence concerns the gene MYL3 and Duchenne muscular dystrophy.